Serum bilirubin level and aortic intima-media thickness in patients without clinical Manifestation of atherosclerotic cardiovascular Disease

Angiology

Volumn 65, Issue 4, 2014, Pages 308-312

  Kalkan, Gülhan Yüksel ^a   Gür, Mustafa ^a   Baykan, Ahmet Oytun ^a   Koyunsever, Nermin Yildiz ^a   Kaypakli, Onur ^a   Sen, Omer ^a   Kuloǧlu, Osman ^a   Şeker, Taner ^a   Uçar, Hakan ^a   Akyol, Selehattin ^a   Elbasan, Zafer ^a   Şahin, Durmuş Yildiray ^a   Çayli, Murat ^a  

^a ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

aorta; atherosclerosis; bilirubin; intima media thickness

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BILIRUBIN BLOOD LEVEL; FEMALE; HUMAN; INTRACARDIAC ECHOGRAPHY DEVICE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REVIEW; SENSITIVITY ANALYSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTA; ATHEROSCLEROSIS; BILIRUBIN; INTIMA-MEDIA THICKNESS;

ADULT; AORTA, THORACIC; AORTIC DISEASES; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BILIRUBIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84895491206     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713507627     Document Type: Review

References (33)

1. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987 ; 235 (4792). 1043-1046
2. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994 ; 269 (24). 16712-16719
3. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem. 2000 ; 46 (11). 1723-1727
4. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994 ; 40 (1). 18-23
5. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995 ; 41 (10). 1504-1508
6. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med. 2003 ; 228 (5). 568-571
7. Ajja R, Lee DC, Sui X, Church TS, Steven NB. Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men. Am J Cardiol. 2011 ; 108 (10). 1438-1442
8. Ganotakis ES, Vrentzos GE, Gazi IF, et al. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007 ; 21 (4). 685-694
9. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J. 2010 ; 51 (2). 86-91
10. Bremier LH. Where are we now with bilirubin as a marker of vascular risk?. Angiology. 2014 ; 65 (3). 177-179
11. Rohani M, Jogestrand T, Ekberg M, et al. Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis. 2005 ; 179 (2). 311-316
12. Belhassen L, Carville C, Pelle G, et al. Evaluation of carotid artery and aortic intima-media thickness measurements for exclusion of significant coronary atherosclerosis in patients scheduled for heart valve surgery. J Am Coll Cardiol. 2002 ; 39 (7). 1139-1144
13. Harrington J, Pena AS, Gent R, Hirte C, Couper J. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr. 2010 ; 156 (2). 237-241
14. Lang RM, Bierig M, Devereux RB, et al. American society of echocardiography's nomenclature and standards committee; task force on chamber quantification; American college of cardiology echocardiography committee; American heart association; European association of echocardiography, European society of cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006 ; 7 (2). 79-108
15. Nishino M, Masugata H, Yamada Y, Abe H, Hori M, Kamada T. Evaluation of thoracic aortic atherosclerosis by transesophageal echocardiography. Am Heart J. 1994 ; 127 (2). 336-344
16. Yamaguchi T, Terakado M, Horio F, Aoki K, Tanaka M, Nakajima H. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun. 1996 ; 223 (1). 129-135
17. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?. Cardiovasc Res. 1999 ; 41 (2). 385-394
18. Stocker R, Glaser AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA. 1987 ; 84 (16). 5918-5922
19. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for a-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem. 1994 ; 269 (24). 16712-16719
20. Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than rolox. Life Sci. 1994 ; 54 (25). 477-481
21. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996 ; 51 (6). 859-862
22. Erdogan D, Gullu H, YIldIrIm E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006 ; 184 (2). 431-437
23. Wang HY, Han P, Zhang WH, et al. Serum bilirubin level is negatively correlated with disease progression of peripheral arterial disease: an observational cohort study. Angiology. 2012 ; 63 (4). 248-53
24. Wu TW. Is serum bilirubin a risk factor for coronary artery disease?. Clin Chem. 1994 ; 40 (1). 9-10
25. Libby P. Inflammation in atherosclerosis. Nature. 2002 ; 420 (6917). 868-874
26. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004 ; 84 (4). 1381-1478
27. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol. 2005 ; 25 (7). 1332-1340
28. Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, Chung HT. 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis. 2006 ; 187 (2). 274-284
29. VItek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002 ; 160 (2). 449-456
30. Yoshino S, Hamasaki S, Ishida S, et al. Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol. Heart Vessels. 2013 ; 28 (2). 157-165
31. Fluiter K, Sattler W, De Beer MC, Connell PM, van der Westhuyzen DR, van Berkel TJ. Scavenger receptor BI mediates the selective uptake of oxidized cholesterol esters by rat liver. J Biol Chem. 1999 ; 274 (13). 8893-8899
32. Schwertner HA. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis. 1998 ; 136 (2). 383-387
33. Madhavan M, Wattigney WA, Srinivasan SR, Berenson GS. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis. 1997 ; 131 (1). 107-113